Clinical Trial

Effect of Early Neuromodulation Coupled With Rehabilitation on the Prevention of Post-stroke Pain

Study acronym: ENADA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective clinical study to evaluate the efficacy of tDCS stimulation, coupled with conventional rehabilitation, on the development of post-stroke neuropathic pain. The study involves a double-blind, randomized, sham-controlled experimental protocol involving 2 parallel groups with patients allocated according to a Fleming design (40 patients in the active group, 20 patients in the control group). The study is aimed at sub-acute post-stroke patients. After recruitment, they will receive 10 sessions of tDCS stimulation (2mA, 20 minutes with a current on/off ramp of 0.1 mA/s). For the control group, stimulation will stop after the current ramp.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-23.
Trial Details
NCT Number NCT07202455
Lead Sponsor University Hospital, Clermont-Ferrand
Conditions Stroke, Neuropathic Pain, Central Post Stroke Pain
Enrollment 60 participants
Start Date 2026-01-01
Primary Completion 2029-04-30 (estimated)
Study Completion 2029-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-23